medigraphic.com
ISSN 1527-3172 (Electronic)

2011, Number 2

<< Back Next >>

MEDICC Review 2011; 13 (2)

HIV detection in Cuba: Role and results of the National Laboratory Network

Díaz HM, Pérez MT, Lubián AL, Nibot C, Cruz O, Silva E, Rolo F, Izquierdo M

Language: English
References: 24
Page: 9-13
PDF size: 197.30 Kb.


Text Extraction

Timely and accurate detection of HIV infection is critical due to the seriousness of AIDS and its impact on individuals and families, the long symptom-free incubation period, the benefi ts of enrolling patients as early as possible in therapy and follow-up, and as a pillar of population-based prevention strategies aimed at curbing the epidemic. Thus, an essential component of Cuba’s National HIV/AIDS Program (full title, National Program for Prevention and Control of Sexually-Transmitted Diseases and HIV/AIDS) is laboratory diagnosis, based on an extensive laboratory network, effective confirmatory algorithms and quality control with external evaluation.


REFERENCES

  1. Ministry of Public Health (CU). Plan Estratégico Nacional ITS/VIH/sida 2001–2006. Resolución No. 110 del Ministerio de Salud Pública [Internet]. Havana: Ministry of Public Health (CU); 2001 Oct [cited 2010 Aug 9]. 82 p. Available from: http://www.sld.cu/galerias/pdf/estrategia. pdf . Spanish.

  2. Santín M, Lantero MI, Ochoa R, Joanes J, Pérez JL, González L, et al. Programa Nacional de Prevención y Control de las ITS-VIH-sida. Informe Nacional sobre los progresos realizados en la aplicación del UNGASS. La Habana. República de Cuba [Internet]. Geneva: UNAIDS; 2008 Jan [cited 2010 Aug 9]. 39 p. Available from: http:// data.unaids.org/pub/Report/2008/cuba_2008_ country_progress_report_sp_es.pdf . Spanish.

  3. Ministry of Public Health (CU). Área de Higiene y Epidemiología. Programa Nacional de Prevención y Control del VIH/SIDA. Havana: Servimpres; 1997. p. 2–3. Spanish.

  4. Ministry of Public Health (CU). Regulación No 8. 2001 [Internet]. Havana: Centro para el Control Estatal de los Medicamentos [Government Center for Quality Control of Medicines]; 2001[updated 2010 May; cited 2010 Aug 9]. Available from: http://www.cecmed.sld.cu. Spanish.

  5. US. Public health service guidelines for testing and counseling blood and plasma donors for human immunodefi ciency virus type 1. MMWR Recomm Rep. 1996 Mar 1;45(RR-2): 1–9.

  6. Jackson JB, Balfour HH Jr. Practical diagnostic testing for human immunodefi ciency virus. Clin Microbiol Rev. 1988 Jan;1(1):124–38.

  7. Constantine NT. HIV Antibody Assays [Internet]. California: Regents of the University of California; c2011. HIV InSite Knowledge Base Chapter May 2006; 2006 May [cited 2007 May 16]; [about 26 p.]. Available from: http://hivinsite.ucsf.edu/ InSite?page=kb-02-02-01

  8. CECMED. Regulación 47/2007. Requisitos para la evaluación del desempeño de los diagnosticadores. Ambito Regulador [Internet]. 2007 Jun [cited 2010 Feb 17];8(boletín especial). Available from: http://www.cecmed.sld.cu/Docs/Pubs/AmbReg/ 2007/AmbReg_SEJun_07.pdf. Spanish.

  9. WHO. Global Programme on AIDS. Recomendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec. 1992 May 15;67(20):145–9.

  10. Morales E, Alonso V, Pozo L, González A, Figueiras Y, González A, et al. Evaluación de la Aplicación del ensayo UMELISA HIV 1+2 RECOMBINANT en muestras de sangre seca sobre papel de fi ltro S&S 903. Rev Biomed. 2004 Jul– Sep;15(3):149–55. Spanish.

  11. Schelstraete B, Bijnens BB, Wuyts G. Evaluation of Organon Teknika Vironostika UIV Uni-Form II Ag/Ab on the Ortho Summit Processor. J Am Assoc Blood Banks. 1999;39(10 Suppl):74S.

  12. Lubián L, Nibot C, Az HM, Martin RZ. Comparison of Two Different Generations Assays from Organon Teknika for the HIV Laboratory Diagnosis. 14th International Conference on AIDS; 2002 July 7-12; Barcelone, Spain [CD-ROM]. Italy: Monduzzi Editore International Proceedings Division; 2002. 7 CD-ROM.

  13. WHO. Acquired immunodefi ciency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western Blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Wkly Epidemiol Rec. 1990 Sep 14;65(37):281–3.

  14. Tamashiro H, Fauquex A, Heymann D, Emmanuel J, Sato P, Maskill W. Reducing cost of HIV antibody testing. Lancet.1993 Jul 10;342(8863):87–90.

  15. González Núñez I, Dosal Caruso L, Díaz Jidy M, Pérez J. Atención del niño cubano hijo de madres seropositivas al VIH/SIDA. Rev Cubana Med Trop. 1995;47(3):202–8. Spanish.

  16. González Núñez I, Díaz Jidy M, Pérez Ávila J. Cuban program for prevention of mother to child HIV/ AIDS transmission. MEDICC Rev. 2001;3:(1–2).

  17. UNAIDS. Guidelines for organizing national external quality assessment schemes for HIV serological testing [Internet]. Geneva: World Health Organization; 1996 Jan [cited 2010 Aug 9]. 39 p. Available from: http://www.who.int/diagnostics_ laboratory/quality/en/EQAS96.pdf

  18. Jacobson RH. Validación de pruebas serológicas para el diagnóstico de enfermedades infecciosas. Rev Sci Tech Off Int Epiz. 1998;17:507–26.

  19. PAHO. Manual de procedimientos de control de calidad para los laboratorios de serología de los bancos de sangre. Washington DC: Pan- American Health Organization; 1994 Feb. 50 p. Spanish.

  20. Andersson S, Thorstensson R, Ramirez KG, Krook A, von Sydow M, Dias F, et al. Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa. Transfusion. 1999 Aug;39(8):845–51.

  21. Argote E, López G. Pautas para evaluar la calidad de los juegos diagnósticos basados en la técnica de ELISA. Rev Cub Cienc Vet. 1995;24(2):16–9. Spanish.

  22. UNAIDS. Situación de la epidemia de sida diciembre 2009 [Internet]. Geneva: World Health Organization; 2009 Dec [cited 2010 Aug 9]. 100 p. Available from: http://data.unaids.org/pub/ Report/2009/jc1700_epi_update_2009_es.pdf. Spanish.

  23. Kashyap B, Gautam H, Chadha S, Bhalla P. Delayed progression and ineffi cient transmission of HIV-2. Southeast Asian J Trop Med Public Health. 2010 May;41(3):570–3.

  24. Xunta de Galicia, Organización Panamericana de la Salud. Epidat 3.1: análisis epidemiológico de datos tabulados [Internet]. Santiago de Compostela: Xunta de Galicia, OPS; 2006 [cited 2009 Nov 26]. Available from: http://dxsp. sergas.es/ApliEdatos/Epidat/cas/default.asp. Spanish.




2020     |     www.medigraphic.com